Dana Farber Cancer Institute (DFCI) (Adults and Pediatrics) is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Dana Farber Cancer Institute (DFCI) (Adults and Pediatrics) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD).
Sponsors: Pierre Fabre Medicament.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana Farber Cancer Institute (DFCI) (Adults and Pediatrics) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana Farber Cancer Institute (DFCI) (Adults and Pediatrics) has 1 clinical trials on record, with 1 currently active. Their work covers Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD).
Dana Farber Cancer Institute (DFCI) (Adults and Pediatrics) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.